Small details, great impacts: Controlled antibody anchoring for enhanced immunoassays

Zhiwei Liu1, Jian Yang2, Zhouyi Xiong2

  • 1School of Life and Health Technology, Dongguan University of Technology, Dongguan 523808, China; Dongguan Food Industry Technology Innovation Center, Dongguan 523808, China.

Immunoassays are essential tools in clinical diagnostics, food safety surveillance, and environmental monitoring; however, a persistent discrepancy exists between the theoretical performance of bioreceptors and their practical efficacy in sensor devices. This performance gap is largely rooted in the stochastic nature of antibody anchoring at sensing interfaces, which frequently causes surface-induced denaturation, orientational heterogeneity, and steric occlusion. This review provides a microscopic framework to elucidate these deleterious interfacial behaviors and advocates a shift from empirical trial-and-error practices toward rational, controllable interface design. We systematically categorize and evaluate strategies for controlled antibody anchoring along a passive-to-active regulation spectrum. Passive positioning strategies, including affinity-mediated capture and site-defined chemical anchoring, use external binding mediators or localized antibody modifications to guide antibodies into functional postures. By contrast, active programming approaches, including genetically engineered antibodies and anchoring guided by intrinsic antibody properties, elevate antibodies into autonomous structural components that direct their own spatial integration at interfaces. Furthermore, exploratory concepts from adjacent disciplines and possible long-range conformational effects of antibody anchoring are also briefly considered as complementary perspectives for future interface design. To resolve the field's fragmented evaluation metrics, we propose a reporting framework that integrates key measurements needed to support claims of improved antibody anchoring. Finally, challenges and future directions are outlined, emphasizing the integration of computational interface engineering, AI-guided protein design, and standardized evaluation protocols. Together, these advances chart a clear path toward predictable, robust, and optimized immunosensing platforms.

Related Concept Videos

Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.